Gamunex

immunoglobulin G (IgG) subcutaneous formulation · Grifols Therapeutics LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gamunex, covering 2012-12-18 to 2012-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency [Phase 2]

See pricing